Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of oral HPP737 in adults with mild to moderate atopic dermatitis
CTR20210514Phase 2Completed
- Sponsor
- Hengyi Biopharmaceutical
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HPP737 in atopic dermatitis (AD), sponsored by Hengyi Biopharmaceutical. Started Jun 2021; status: completed.
02
Drugs
HPP737
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on CTR20210514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210514.